According to British Society for Haematology (BSH) guidelines and NICE Clinical Knowledge Summaries (CKS), the primary beneficiaries include: Key patient groups who may require B12 injections include: Pernicious anaemia patients requiring lifelong hydroxocobalamin 1mg intramuscularly every 23 months following initial loading doses Patients with gastrointestinal disorders including those who have undergone gastrectomy or ileal resection, and patients with conditions affecting B12 absorption such as Crohn's disease or coeliac disease Strict vegans and vegetarians though oral supplementation is usually sufficient unless malabsorption is present Elderly patients who may have reduced gastric acid production affecting B12 absorption Patients taking certain medications including metformin (MHRA advises monitoring B12 levels in long-term users, particularly those with risk factors or symptoms), proton pump inhibitors, and H2-receptor antagonists long-term [6] Individuals with neurological symptoms such as paraesthesia, ataxia, or cognitive impairment related to B12 deficiency Pregnant women with confirmed deficiency (hydroxocobalamin for malabsorption

Whether youre recovering from a weekend injury on the water in Greenwich, dealing with chronic tendinopathy while training for a local triathlon, or managing a gut condition that conventional medicine hasnt fully addressed the goal is the same: structural repair, not just symptom masking
Please note that we do not dispatch shipments on Fridays or on days before official public holidays
Who should avoid AHK-Cu Individuals with copper metabolism disorders, specifically Wilson disease or Menkes disease, should not use copper peptides without medical guidance
Starting at full dose would cause severe nausea in most users